Cheng-Ming Sun Selected Research

Cheng-Ming Sun Research Topics

12	Neoplasms (Cancer) 01/2024 - 01/2016
5	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 06/2020
5	Inflammation (Inflammations) 01/2022 - 04/2005
2	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 01/2020
1	Thrombotic Microangiopathies 01/2022
1	Heart Failure 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Digestive System Diseases 01/2022
1	Liver Failure 01/2022
1	Massive Hepatic Necrosis 01/2022
1	Tertiary Lymphoid Structures 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 10/2020
1	Kidney Neoplasms (Kidney Cancer) 06/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Infections 04/2019
1	Deafness (Deaf Mutism) 01/2015
1	Gestational Diabetes (Gestational Diabetes Mellitus) 08/2014
1	Communicable Diseases (Infectious Diseases) 03/2002

6	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2020
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 06/2020
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2020
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2019
2	IpilimumabIBA 01/2022 - 06/2020
2	NivolumabIBA 01/2022 - 06/2020
2	AntibodiesIBA 01/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2019
2	Interleukin-10 (Interleukin 10)IBA 01/2016 - 04/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024
1	TrabectedinIBA 01/2024
1	RNA (Ribonucleic Acid)IBA 01/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2023
1	AnaphylatoxinsIBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	AntigensIBA 01/2021
1	MTOR InhibitorsIBA 06/2020
1	CytokinesIBA 01/2020
1	Complement C5a (Complement 5a)IBA 01/2019
1	Complement C1q (C1q Complement)IBA 01/2019
1	Cancer VaccinesIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	12S ribosomal RNAIBA 01/2015
1	Insulin Receptor Substrate ProteinsIBA 08/2014
1	Melatonin Receptors (Melatonin Receptor)IBA 08/2014
1	Interleukin-12 (IL 12)IBA 04/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2005
1	VaccinesIBA 03/2002